CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
bioactive glass (sol-gel) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01878084
NCT01878084N/ACompleted
CompareCT.gov

Phase I/II Trial of Alveolar Bone Engineering Using Bioactive Glass (Sol-Gel) Immediately After Premolar Extraction in Patients Requiring Orthodontic Treatment

Alexandria University·interventional·Posted Jun 14, 2013·Updated Feb 18, 2020

In Brief

A clinical study evaluating bioactive glass (sol-gel) and empty extraction socket for Bone Loss and 2 related conditions. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The purpose of the present research is to evaluate the effect of bioactive glass in bone regeneration immediately following extraction of mandibular and maxillary premolars.The hypothesis of the study assumes that this treatment would promote the healing of the extraction socket while preserving both the height and width of the bone. Furthermore, it would allow more effective tooth movement during orthodontic treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Loss, Vertical Alveolar Bone Loss, Horizontal Alveolar Bone Loss
CountriesEgypt
CollaboratorsLehigh University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 14, 2013
Enrollment StartOct 1, 2013
Primary CompletionDec 1, 2016
Study CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 13.0 years ago

Interventions

bioactive glass (sol-gel)other

Extraction sockets will be augmented using bioactive glass (sol-gel)

empty extraction socketother

Extraction socket will be left empty